HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.

Abstract
As interleukin (IL)-13 and IL-4 play a major role in various diseases including asthma, allergy, and malignancies, it is desirable to generate a molecule that blocks the effects of both cytokines. We previously generated a human IL-13 mutant (IL-13E13K), which is a powerful antagonist of IL-13, blocking the biological activities of IL-13. We now show that IL-13E13K also competitively inhibits signaling and biological activities of IL-4 through type II and partially through type III IL-4 receptor (R) system. IL-13E13K completely blocked the IL-4-induced phosphorylation of STAT6 and IL-4-dependent protein synthesis in cells expressing type II and partially type III IL-4R but not type I IL- 4R. Consistent with the inhibition of biological activities, IL-13E13K inhibited IL-4 binding to type II IL-4R-expressing cells but not to type I IL-4R-expressing cells. The inhibition efficiency of IL-4 binding by IL-13E13K was relatively lower compared to wtIL-13 even though IL-13E13K bound to IL-13Ralpha1 positive cells with a similar affinity to wtIL-13. These results indicate that Glu13 in IL-13 associates with IL-4Ralpha, and mutation to lysine decreases its binding ability to IL-4Ralpha chain. IL-13E13K binds to IL- 13Ralpha1, which is shared by both IL-13R and IL-4R systems. Consequently, IL-13E13K inhibits IL-4 binding to these cells and prevents heterodimer formation between IL-13Ralpha1 and IL-4Ralpha chains. This interference by IL-13E13K blocks the biological activities of not only IL-13 but also partially of IL-4. Thus, IL-13E13K may be a useful agent for the treatment of diseases such as asthma, allergic rhinitis, and cancer, which are dependent on signaling through both IL-4 and IL-13 receptors.
AuthorsMitomu Kioi, Koji Kawakami, Raj K Puri
JournalCellular immunology (Cell Immunol) Vol. 229 Issue 1 Pg. 41-51 (May 2004) ISSN: 0008-8749 [Print] Netherlands
PMID15331327 (Publication Type: Journal Article)
Chemical References
  • Bacterial Toxins
  • Exotoxins
  • Interleukin-13
  • Receptors, IgE
  • Receptors, Interleukin-4
  • interleukin 13 antagonist E13K
  • interleukin-4-Pseudomonas exotoxin
  • Interleukin-4
Topics
  • Animals
  • B-Lymphocytes (metabolism)
  • Bacterial Toxins (metabolism)
  • COS Cells
  • Chlorocebus aethiops
  • Exotoxins (metabolism)
  • Humans
  • Interleukin-13 (antagonists & inhibitors, metabolism)
  • Interleukin-4 (metabolism)
  • Jurkat Cells
  • Protein Biosynthesis (physiology)
  • Receptors, IgE (biosynthesis)
  • Receptors, Interleukin-4 (metabolism)
  • Signal Transduction (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: